An anti-inflammatory role for N-acetyl aspartate in stimulated human astroglial cells

Biochemical and Biophysical Research Communications

Volumn 319, Issue 3, 2004, Pages 847-853

  Rael, Leonard T ^a,b   Thomas, Gregory W ^a,b   Bar Or, Raphael ^b   Craun, Michael L ^a   Bar Or, David ^a,b  

^a SWEDISH MEDICAL CENTER   (United States)

^b DMI BioSciences Inc   (United States)

Author keywords

Astrocyte astroglia ; Cyclooxygenase; Inhibition; Intracellular calcium; N Acetyl aspartate; NF B; Prostaglandin

Indexed keywords

CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; IONOMYCIN; N ACETYLASPARTIC ACID;

ACETYLATION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTE; CELL STIMULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL;

ANILINE COMPOUNDS; ANTI-INFLAMMATORY AGENTS; ASPARTIC ACID; ASTROCYTES; CALCIUM; CELL LINE; CYCLOOXYGENASE 2; DINOPROSTONE; FLUORESCENT DYES; HUMANS; I-KAPPA B PROTEINS; INTERLEUKIN-1; IONOMYCIN; IONOPHORES; ISOENZYMES; MEMBRANE PROTEINS; NF-KAPPA B; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; TETRADECANOYLPHORBOL ACETATE; XANTHENES;

EID: 2942567955     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.04.200     Document Type: Article

References (46)

1. Baslow M.H. A review of phylogenetic and metabolic relationships between the acylamino acids, N-acetyl-L-aspartic acid and N-acetyl-L-histidine, in the vertebrate nervous system. J. Neurochem. 68:1997;1335-1344
2. Clark J.B. N-Acetyl aspartate: a marker for neuronal loss or mitochondrial dysfunction. Dev. Neurosci. 20:1998;271-276
3. Tsai G., Coyle J.T. N-Acetylaspartate in neuropsychiatric disorders. Prog. Neurobiol. 46:1995;531-540
4. Jacobs M.A., Horska A., van Zijl P.C., Barker P.B. Quantitative proton MR spectroscopic imaging of normal human cerebellum and brain stem. Magn. Reson. Med. 46:2001;699-705
5. 1H magnetic resonance spectroscopy. Magn. Reson. Med. 39:1998;28-33
6. Pouwels P.J., Frahm J. Differential distribution of NAA and NAAG in human brain as determined by quantitative localized proton MRS. NMR Biomed. 10:1997;73-78
7. Soher B.J., van Zijl P.C., Duyn J.H., Barker P.B. Quantitative proton MR spectroscopic imaging of the human brain. Magn. Reson. Med. 35:1996;356-363
8. Friedman S.D., Brooks W.M., Jung R.E., Hart B.L., Yeo R.A. Proton MR spectroscopic findings correspond to neuropsychological function in traumatic brain injury. AJNR Am. J. Neuroradiol. 19:1998;1879-1885
9. Baslow M.H. N-Acetylaspartate in the vertebrate brain: metabolism and function. Neurochem. Res. 28:2003;941-953
10. Jenkins B.G., Klivenyi P., Kustermann E., Andreassen O.A., Ferrante R.J., Rosen B.R., Beal M.F. Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose transgenic Huntington's disease mice. J. Neurochem. 74:2000;2108-2119
11. Suhy J., Miller R.G., Rule R., Schuff N., Licht J., Dronsky V., Gelinas D., Maudsley A.A., Weiner M.W. Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI. Neurology. 58:2002;773-779
12. Huang W., Alexander G.E., Chang L., Shetty H.U., Krasuski J.S., Rapoport S.I., Schapiro M.B. Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study. Neurology. 57:2001;626-632
13. Konaka K., Ueda H., Li J.Y., Matsumoto M., Sakoda S., Yanagihara T. N-Acetylaspartate to total creatine ratio in the hippocampal CA1 sector after transient cerebral ischemia in gerbils: influence of neuronal elements, reactive gliosis, and tissue atrophy. J. Cereb. Blood Flow Metab. 23:2003;700-708
14. Wylezinska M., Cifelli A., Jezzard P., Palace J., Alecci M., Matthews P.M. Thalamic neurodegeneration in relapsing-remitting multiple sclerosis. Neurology. 60:2003;1949-1954
15. Iranzo A., Moreno A., Pujol J., Marti-Fabregas J., Domingo P., Molet J., Ris J., Cadafalch J. Proton magnetic resonance spectroscopy pattern of progressive multifocal leukoencephalopathy in AIDS. J. Neurol. Neurosurg. Psychiatry. 66:1999;520-523
16. 1H-MR spectroscopy and gray matter volume of the anterior cingulate cortex in schizophrenia. NeuroReport. 13:2002;2133-2137
17. Sager T.N., Fink-Jensen A., Hansen A.J. Transient elevation of interstitial N-acetylaspartate in reversible global brain ischemia. J. Neurochem. 68:1997;675-682
18. Sager T.N., Thomsen C., Valsborg J.S., Laursen H., Hansen A.J. Astroglia contain a specific transport mechanism for N-acetyl-L-aspartate. J. Neurochem. 73:1999;807-811
19. Huang W., Wang H., Kekuda R., Fei Y.J., Friedrich A., Wang J., Conway S.J., Cameron R.S., Leibach F.H., Ganapathy V. Transport of N-acetylaspartate by the Na(+)-dependent high-affinity dicarboxylate transporter NaDC3 and its relevance to the expression of the transporter in the brain. J. Pharmacol. Exp. Ther. 295:2000;392-403
20. Chakraborty G., Mekala P., Yahya D., Wu G., Ledeen R.W. Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin-associated aspartoacylase. J. Neurochem. 78:2001;736-745
21. Baslow M.H. Evidence supporting a role for N-acetyl-L-aspartate as a molecular water pump in myelinated neurons in the central nervous system. An analytical review. Neurochem. Int. 40:2002;295-300
22. Ouellet M., Riendeau D., Percival M.D. A high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxygenase-1 inactivation by aspirin. Proc. Natl. Acad. Sci. USA. 98:2001;14583-14588
23. Wang Z., Tymianski M., Jones O.T., Nedergaard M. Impact of cytoplasmic calcium buffering on the spatial and temporal characteristics of intercellular calcium signals in astrocytes. J. Neurosci. 17:1997;7359-7371
24. Tegeder I., Pfeilschifter J., Geisslinger G. Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB J. 15:2001;2057-2072
25. Lecomte M., Laneuville O., Ji C., DeWitt D.L., Smith W.L. Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin. J. Biol. Chem. 269:1994;13207-13215
26. Kawamori T., Uchiya N., Sugimura T., Wakabayashi K. Enhancement of colon carcinogenesis by prostaglandin E2 administration. Carcinogenesis. 24:2003;985-990
27. Lim S.C. Role of COX-2, VEGF and cyclin D1 in mammary infiltrating duct carcinoma. Oncol. Rep. 10:2003;1241-1249
28. Kyrkanides S., Moore A.H., Olschowka J.A., Daeschner J.C., Williams J.P., Hansen J.T., Kerry O'Banion M. Cyclooxygenase-2 modulates brain inflammation-related gene expression in central nervous system radiation injury. Brain Res. Mol. Brain Res. 104:2002;159-169
29. Bentzer P., Venturoli D., Carlsson O., Grande P.O. Low-dose prostacyclin improves cortical perfusion following experimental brain injury in the rat. J. Neurotrauma. 20:2003;447-461
30. Rage F., Lee B.J., Ma Y.J., Ojeda S.R. Estradiol enhances prostaglandin E2 receptor gene expression in luteinizing hormone-releasing hormone (LHRH) neurons and facilitates the LHRH response to PGE2 by activating a glia-to-neuron signaling pathway. J. Neurosci. 17:1997;9145-9156
31. Matalon R.M., Michals-Matalon K. Spongy degeneration of the brain, Canavan disease: biochemical and molecular findings. Front. Biosci. 5:2000;D307-D311
32. Baslow M.H., Resnik T.R. Canavan disease. Analysis of the nature of the metabolic lesions responsible for development of the observed clinical symptoms. J. Mol. Neurosci. 9:1997;109-125
33. John G.R., Scemes E., Suadicani S.O., Liu J.S., Charles P.C., Lee S.C., Spray D.C., Brosnan C.F. IL-1beta differentially regulates calcium wave propagation between primary human fetal astrocytes via pathways involving P2 receptors and gap junction channels. Proc. Natl. Acad. Sci. USA. 96:1999;11613-11618
34. Parpura V., Haydon P.G. Physiological astrocytic calcium levels stimulate glutamate release to modulate adjacent neurons. Proc. Natl. Acad. Sci. USA. 97:2000;8629-8634
35. Grohn O., Kauppinen R. Intracellular chelation of calcium prevents cell damage following severe hypoxia in the rat cerebral cortex as studied by NMR spectroscopy ex vivo. Cell Calcium. 20:1996;509-514
36. Rubin Y., Connelly G.P., Lenkinski R.E. N-Acetylaspartate complexes with calcium and lanthanide ions. J. Inorg. Biochem. 60:1995;31-43
37. Venance L., Stella N., Glowinski J., Giaume C. Mechanism involved in initiation and propagation of receptor-induced intercellular calcium signaling in cultured rat astrocytes. J. Neurosci. 17:1997;1981-1992
38. Bezzi P., Carmignoto G., Pasti L., Vesce S., Rossi D., Rizzini B.L., Pozzan T., Volterra A. Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature. 391:1998;281-285
39. Sanzgiri R.P., Araque A., Haydon P.G. Prostaglandin E(2) stimulates glutamate receptor-dependent astrocyte neuromodulation in cultured hippocampal cells. J. Neurobiol. 41:1999;221-229
40. Schwenger P., Alpert D., Skolnik E.Y., Vilcek J. Activation of p38 mitogen-activated protein kinase by sodium salicylate leads to inhibition of tumor necrosis factor-induced IkappaB alpha phosphorylation and degradation. Mol. Cell. Biol. 18:1998;78-84
41. Murono S., Yoshizaki T., Sato H., Takeshita H., Furukawa M., Pagano J.S. Aspirin inhibits tumor cell invasiveness induced by Epstein-Barr virus latent membrane protein 1 through suppression of matrix metalloproteinase-9 expression. Cancer Res. 60:2000;2555-2561
42. Muller D.N., Heissmeyer V., Dechend R., Hampich F., Park J.K., Fiebeler A., Shagdarsuren E., Theuer J., Elger M., Pilz B., Breu V., Schroer K., Ganten D., Dietz R., Haller H., Scheidereit C., Luft F.C. Aspirin inhibits NF-kappaB and protects from angiotensin II-induced organ damage. FASEB J. 15:2001;1822-1824
43. Camacho M., Godessart N., Anton R., Garcia M., Vila L. Interleukin-1 enhances the ability of cultured human umbilical vein endothelial cells to oxidize linoleic acid. J. Biol. Chem. 270:1995;17279-17286
44. Friedman W.J., Thakur S., Seidman L., Rabson A.B. Regulation of nerve growth factor mRNA by interleukin-1 in rat hippocampal astrocytes is mediated by NFkappaB. J. Biol. Chem. 271:1996;31115-31120
45. Nomoto Y., Yamamoto M., Fukushima T., Kimura H., Ohshima K., Tomonaga M. Expression of nuclear factor kappaB and tumor necrosis factor alpha in the mouse brain after experimental thermal ablation injury. Neurosurgery. 48:2001;158-166
46. Parker L.C., Luheshi G.N., Rothwell N.J., Pinteaux E. IL-1 beta signaling in glial cells in wildtype and IL-1RI deficient mice. Br. J. Pharmacol. 136:2002;312-320